All articles tagged with #montelukast
A Northwestern University study finds that montelukast, an FDA-approved asthma drug that blocks CysLTR1, can reprogram pro-tumor neutrophils and slow tumor growth in mice and human tumor samples, improving immunotherapy responses across several cancers, including triple-negative breast cancer—potentially fast-tracked to trials since the drug is already approved.
Parents of a 14-year-old boy who died by suicide are outraged over the lack of warnings about the potential psychiatric side effects of the asthma drug montelukast, which he had been prescribed. The drug, prescribed for asthma and allergies, has been linked to aggression, depression, and suicidal thoughts. Despite warnings from a UK action group and reports of adverse effects in children, the drug has not been properly monitored or labeled with potential risks. Families are calling for more prominent warnings and better monitoring of patients on the drug, while the Medicines and Healthcare Products Regulatory Agency has confirmed that the drug is under review.